Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2007

Open Access 01.12.2007 | Research

Imprint cytology on microcalcifications excised by Vacuum-Assisted Breast Biopsy: A rapid preliminary diagnosis

verfasst von: Maria Fotou, Vassiliki Oikonomou, Flora Zagouri, Theodoros N Sergentanis, Afroditi Nonni, Pauline Athanassiadou, Theodora Drouveli, Efstratios atsouris, Evagelia Kotzia, George C Zografos

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2007

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

To evaluate imprint cytology in the context of specimens with microcalcifications derived from Vacuum-Assisted Breast Biopsy (VABB).

Patients and methods

A total of 93 women with microcalcifications BI-RADS 3 and 4 underwent VABB and imprint samples were examined. VABB was performed on Fischer's table using 11-gauge Mammotome vacuum probes. A mammogram of the cores after the procedure confirmed the excision of microcalcifications. For the application of imprint cytology, the cores with microcalcifications confirmed by mammogram were gently rolled against glass microscope slides and thus imprint smears were made. For rapid preliminary diagnosis Diff-Quick stain, modified Papanicolaou stain and May Grunwald Giemsa were used. Afterwards, the core was dipped into a CytoRich Red Collection fluid for a few seconds in order to obtain samples with the use of the specimen wash. After the completion of cytological procedures, the core was prepared for routine histological study. The pathologist was blind to the preliminary cytological results. The cytological and pathological diagnoses were comparatively evaluated.

Results

According to the pathological examination, 73 lesions were benign, 15 lesions were carcinomas (12 ductal carcinomas in situ, 3 invasive ductal carcinomas), and 5 lesions were precursor: 3 cases of atypical ductal hyperplasia (ADH) and 2 cases of lobular neoplasia (LN). The observed sensitivity and specificity of the cytological imprints for cancer were 100% (one-sided, 97.5% CI: 78.2%–100%). Only one case of ADH could be detected by imprint cytology. Neither of the two LN cases was detected by the imprints. The imprints were uninformative in 11 out of 93 cases (11.8%). There was no uninformative case among women with malignancy.

Conclusion

Imprint cytology provides a rapid, accurate preliminary diagnosis in a few minutes. This method might contribute to the diagnosis of early breast cancer and possibly attenuates patients' anxiety.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-5-40) contains supplementary material, which is available to authorized users.

Competing interests

The author(s) declare that they have no competing interest.

Authors' contributions

MF : conception of the idea of the study, preparation and evaluation of imprint cytological smears
VO : conception of the idea of the study, preparation and evaluation of imprint cytological smears
FZ : writing of the manuscript, performing VABB, comparative evaluation of pathological and cytological results
TNS : statistical analysis, writing of the manuscript, contributing to the design of the study
AN : establishment of pathological diagnosis
PA : revising the manuscript for important intellectual content
TD : contribution to the preparation of cytological smears, evaluation of the analyzed findings
EP : revising the manuscript for important intellectual content, gave the final approval of the version to be published
EK : revising the manuscript for important intellectual content
GCZ : design of the study, responsible for the performance of VABB in all patients
Abkürzungen
VABB
Vacuum-assisted breast biopsy
BI- RADS
Breast Imaging Reporting and Data System
DCIS
ductal carcinoma in situ
IDC
invasive ductal carcinoma
ADH
atypical ductal hyperplasia
LN
lobular neoplasia

Background

The increased use of mammograms has led to the frequent detection of breast lesions, which in turn require further evaluation [1, 2]. The most common mammographic abnormalities found on screening examinations are microcalcifications [3, 4]. Radiographic mammary microcalcifications occur in 30–50% of breast cancer cases and constitute one of the most important diagnostic markers in both benign and malignant lesions of the breast [3, 4]. When suspicious microcalcifications appear on a mammogram, a needle localization core biopsy is recommended, so that breast tissue can be removed and examined under a microscope by a pathologist. Although microcalcifications are the commonest radiological feature of ductal carcinoma in situ (DCIS), about 90% of women with abnormal microcalcifications do not have breast cancer; this highlights the importance of a safe and efficient evaluation [5, 6].
According to the Breast Imaging Reporting and Data System (BI-RADS) of the American College of Radiology, a biopsy is suggested for lesions classified as category 4 (suspicious), and category 5 (highly suggestive of malignancy) [79]. Additionally, a biopsy can be performed in category 3 lesions if the patient or the referring physician insists [9, 10]. Owing to the broad spectrum of the BI-RADS 4 category and the corresponding wide range of malignancy incidence within it, this category is subdivided into group 4A, 4B and 4C [911].
To establish a preoperative diagnosis, excisional biopsies, core needle biopsies [1214] and vacuum-assisted breast biopsies (VABB) have been used [15, 16]. VABB on the Fischer's table has become an integral part of the work-up of patients with suspicious breast lesions, as it is established as a safe and effective technique providing a minimally invasive, faster, and less painful method for sampling microcalcifications seen on mammograms [1723].
Recently, core imprint cytology has been shown to have a high sensitivity in diagnosing malignancy. Imprint cytology is a technique that is used in our centre for breast specimens obtained after the performance of VABB. As far as breast cancer is concerned, imprint cytology has been extensively discussed at the intraoperative level, for the assessment of sentinel lymph nodes [2427], and secondarily at the preoperative level, i.e. diagnosis of breast carcinoma. The significance, rapidity and reliability of the method have been documented in the context of needle core biopsy [2830]. However, to our knowledge, no studies have focused on imprint cytology specimens derived from VABB. The purpose of this study is to evaluate the application on imprint cytology on cores with microcalcifications derived from VABB.

Patients and methods

We describe our experience based on 93 procedures performed for microcalcifications from January 2005 to September 2006, in our Breast Unit on women aged 35–75 years (50.66 ± 9.10, mean ± SD).
Before the VABB, all patients were evaluated by one of the two radiologists assigned to the Breast Imaging Section. For lesions categorized as BI-RADS 3, follow-up was generally recommended. However, VABB was performed in cases where family history was strongly positive or when the patient and referring physician expressed particular concern. In our unit, BI-RADS category 5 cases were directly submitted to open surgical biopsy (operation) in view of the great likelihood of cancer. VABB was performed on digital prone table (Mammotest, Fischer Imaging, Denver, CO, USA) using 11-gauge Mammotome vacuum probes, under local anesthesia. The examination proceeded according to a standard protocol to assure quality control. The surgeon attempted to procure 24 or more cores in each instance. A mammogram of the cores after the procedure confirmed the excision of microcalcifications.
For the application of imprint cytology only the cores with microcalcifications confirmed by mammogram after the procedure were used. On the other hand, for the establishment of the final pathological diagnosis, all the cores obtained by VABB were examined.
The cores were gently rolled against glass microscope slides and thus imprint smears were made. For rapid preliminary diagnosis: i) air dried smears were stained with a Diff-Quick stain, ii) smears were fixed in 95% ethyl alcohol for 20 min and stained with a modified Papanicolaou stain and iii) air dried smears were stained by May Grunwald Giemsa. Afterwards, the cores were dipped into a CytoRich Red Collection fluid for a few seconds in order to obtain samples with the use of the specimen wash. After the completion of cytological procedures, the cores were plunged into formalin and were prepared for routine pathological study. The pathologist was blind to the preliminary cytological results.
Permission has been obtained from the local institutional review board for publication of the findings summarized in this study.

Results

The sample comprised 93 specimens. Among them, 31.2% (29 out of 93) came from BI-RADS 3 lesions, 45.2% (42 out of 93) from BI-RADS 4A lesions, 22.5% (21 out of 93) from BI-RADS 4B lesions and 1.1% from BI-RADS 4C lesions (1 case). According to the pathological examination, 73 lesions were benign (Table 1) and 15 lesions were malignant; the latter comprised 12 DCIS cases and 3 IDC cases. Five lesions were precursor (3 cases of ADH and 2 cases of LN).
Table 1
Spectrum of benign lesions in the sample
 
BIRADS classification
 
Histopathological diagnosis
BI-RADS 3
BI-RADS 4A
BI-RADS 4B
Total
Fibrocystic change 1
10
8
6
24
Fibroadenoma
2
3
1
6
Sclerosing adenosis
8
7
0
15
Adenosis
4
3
4
11
Papilloma
0
3
2
5
Ductal ectasia
2
3
2
7
Epitheliosis with atypia
1
1
0
2
Monckeberg calcific sclerosis
0
0
1
1
Periductal mastitis
1
1
0
2
Total
28
29
16
73
1As the sole finding; when fibrocystic changes coexisted with other, more important disorders, the case was attributed to the latter.
The results of imprint cytology vs. the pathological results are shown in Table 2. Representative cases are shown in Figures 1, 2, 3. The observed sensitivity of the cytological imprints for cancer was 100% (15 true positive/15 malignant cases), since no false negative results appeared. Similarly, the specificity of the method for cancer was 100%, given that there were no false positive cytological diagnoses. Due to the fact that there was total identity of results between the two methods, only the one-sided, 97.5% confidence interval could be calculated for both proportions (sensitivity and specificity), and it was 78.2%–100%.
Table 2
MicrocalcificationCytological and pathological results along with BI-RADS classification
 
Cytological results (with negative pathological results)
Cytological results (with positive pathological results)
Total
 
Benign (true-negative)
Malignant (false-positive)
Uninformative
Benign (false-negative)
True-positive
Uninformative
 
BI-RADS 3
       
Benign
24
0
4
-
-
-
28
Cancer
-
-
-
0
1
0
1
BI-RADS 4A
       
Benign
27
0
2
-
-
-
29
Precursor
-
-
-
3
1a
1 b
5
Cancer
-
-
-
0
8
0
8
BI-RADS 4B
       
Benign
11
0
5
-
-
-
16
Cancer
-
-
-
0
5
0
5
BI-RADS 4C
       
Cancer
-
-
-
0
1
0
1
Total
62
0
11
3
16
1
93
a this case is an ADH lesion
b this case is a LN lesion
As far as precursor lesions are concerned, only one case of ADH could be detected by imprint cytology, i.e. 33.3% of ADH cases [95%CI: 0.8%–90.6%]; the other two cases yielded false-negative imprints (i.e. having a benign appearance). Neither of the 2 LN cases was detected by the imprints, the first yielding an uninformative result and the other one a false negative (having a benign appearance) cytological diagnosis.
Finally, the cytological imprints were uninformative in 11 out of 93 cases (11.8%), irrespectively of BI-RADS classification or histopathological diagnosis. 13.8% (4 out of 29) of BI-RADS 3 cases yielded uninformative specimens, 4.8% (2 out of 42) of BI-RADS 4A cases were uninformative, and the respective percentage was 23.8% (5 out of 21) for BI-RADS 4B lesions. It should be stressed that no uninformative cases existed within the malignant subgroup.

Discussion

The importance of anxiety in the management of breast patients has been well demonstrated in the literature, even during mild medical procedures [32, 33]. It has been reported that patients experience clinically marked levels of anxiety while they undergo breast biopsy, irrespectively of whether it is an open biopsy or core needle biopsy [3436]. Interestingly, the use of oral anxiolytic medication has been proposed, in order to reduce anxiety women experience [37].
An effective means of reducing anxiety could be a reliable immediate diagnosis after VABB. A rapid answer could represent a valuable relief for women, given that a pathological diagnosis might take four to seven days to be made. Imprint cytology is the technique that could give a preliminary diagnosis within a few minutes.
The sensitivity and the specificity of the method regarding malignancies seem to be absolutely satisfactory, since both were 100% in the sample. The lack of false positive diagnoses (specificity 100%) implicates that imprint use is not capable of imposing unjustified additional anxiety upon the patients. Additionally, the lack of false negative results indicates that no tumors escape the method. It is worth mentioning that uninformative samples were not present among malignant cases and thus did not interfere with cancer detection. Thus, a malignant diagnosis by imprint cytology could be considered almost definitive and the patients should be psychologically prepared for the subsequent operation.
According to our sample, the main drawback of the method pertains to the detection of precursor breast lesions (ADH, LN). Due to the small number of ADH cases, the absolute percentage of lesions detected by imprint cytology (33.3%) should be interpreted with caution. This is reflected upon the extremely large confidence interval, which leaves open all possibilities for the future development of the method. The clinicians should bear in mind the problems of the method with respect to precursor lesions, and should thus not over-reassure the patient, unless the final pathologic diagnosis is established. Further studies encompassing larger samples and focusing on precursor lesions are needed.

Conclusion

This study is the first one to describe the application of imprint cytology in the context of microcalcifications excised by VABB. It demonstrates the very satisfactory sensitivity and specificity of the method. Its capability to provide a rapid preliminary diagnosis in a few seconds and a final cytological diagnosis the day after renders it particularly attractive. Further studies, on larger samples are needed to establish the method in the common clinical practice.

Acknowledgements

The Study was approved by the Institute Review board
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://​creativecommons.​org/​licenses/​by/​2.​0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The author(s) declare that they have no competing interest.

Authors' contributions

MF : conception of the idea of the study, preparation and evaluation of imprint cytological smears
VO : conception of the idea of the study, preparation and evaluation of imprint cytological smears
FZ : writing of the manuscript, performing VABB, comparative evaluation of pathological and cytological results
TNS : statistical analysis, writing of the manuscript, contributing to the design of the study
AN : establishment of pathological diagnosis
PA : revising the manuscript for important intellectual content
TD : contribution to the preparation of cytological smears, evaluation of the analyzed findings
EP : revising the manuscript for important intellectual content, gave the final approval of the version to be published
EK : revising the manuscript for important intellectual content
GCZ : design of the study, responsible for the performance of VABB in all patients
Anhänge

Authors’ original submitted files for images

Literatur
1.
Zurück zum Zitat Ringash J: Canadian Preventive Task Force on Preventive Health Care. Preventive health care, 2001 update: screening mammography among women aged 40–49 years at average risk of breast cancer. CMAJ. 2001, 164: 469-476.PubMedCentralPubMed Ringash J: Canadian Preventive Task Force on Preventive Health Care. Preventive health care, 2001 update: screening mammography among women aged 40–49 years at average risk of breast cancer. CMAJ. 2001, 164: 469-476.PubMedCentralPubMed
3.
Zurück zum Zitat Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V: Positive predictive value of screening mammography by age and family history of breast cancer. JAMA. 1993, 270: 2444-2450. 10.1001/jama.270.20.2444.CrossRefPubMed Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V: Positive predictive value of screening mammography by age and family history of breast cancer. JAMA. 1993, 270: 2444-2450. 10.1001/jama.270.20.2444.CrossRefPubMed
4.
Zurück zum Zitat Evans AJ, Wilson AR, Burrell HC, Ellis IO, Pinder SE: Mammographic features of ductal carcinoma in situ (DCIS) present on previous mammography. Clin Radiol. 1999, 54: 644-646. 10.1016/S0009-9260(99)91083-8.CrossRefPubMed Evans AJ, Wilson AR, Burrell HC, Ellis IO, Pinder SE: Mammographic features of ductal carcinoma in situ (DCIS) present on previous mammography. Clin Radiol. 1999, 54: 644-646. 10.1016/S0009-9260(99)91083-8.CrossRefPubMed
5.
Zurück zum Zitat Gulsun M, Demirkazik FB, Ariyurek M: Evaluation of breast microcalcifications according to Breast Imaging Reporting and Data System criteria and Le Gal's classification. Eur J Radiol. 2003, 47: 227-231. 10.1016/S0720-048X(02)00181-X.CrossRefPubMed Gulsun M, Demirkazik FB, Ariyurek M: Evaluation of breast microcalcifications according to Breast Imaging Reporting and Data System criteria and Le Gal's classification. Eur J Radiol. 2003, 47: 227-231. 10.1016/S0720-048X(02)00181-X.CrossRefPubMed
6.
Zurück zum Zitat Gotzche PC, Olsen O: Is screening for breast cancer with mammography Justifiable?. Lancet. 2000, 355: 129-134. 10.1016/S0140-6736(99)06065-1.CrossRef Gotzche PC, Olsen O: Is screening for breast cancer with mammography Justifiable?. Lancet. 2000, 355: 129-134. 10.1016/S0140-6736(99)06065-1.CrossRef
7.
Zurück zum Zitat Orel SG, Kay N, Reynolds C, Sullivan DC: BI-RADS categorization as a predictor of malignancy. Radiology. 1999, 211: 845-850.CrossRefPubMed Orel SG, Kay N, Reynolds C, Sullivan DC: BI-RADS categorization as a predictor of malignancy. Radiology. 1999, 211: 845-850.CrossRefPubMed
8.
Zurück zum Zitat Obenauer S, Hermann KP, Grabbe E: Applications and literature review of the BI-RADS classification. Eur Radiol. 2005, 15: 1027-1036. 10.1007/s00330-004-2593-9.CrossRefPubMed Obenauer S, Hermann KP, Grabbe E: Applications and literature review of the BI-RADS classification. Eur Radiol. 2005, 15: 1027-1036. 10.1007/s00330-004-2593-9.CrossRefPubMed
9.
Zurück zum Zitat Kerlikowske K, Smith-Bindman R, Ljung BM, Grady D: Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med. 2003, 139: 274-285.CrossRefPubMed Kerlikowske K, Smith-Bindman R, Ljung BM, Grady D: Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med. 2003, 139: 274-285.CrossRefPubMed
10.
Zurück zum Zitat American College of Surgeons and American College of Radiology: Physician qualifications for stereotactic breast biopsy: a revised statement. Bull Am Coll Surg. 1998, 83: 30-33. American College of Surgeons and American College of Radiology: Physician qualifications for stereotactic breast biopsy: a revised statement. Bull Am Coll Surg. 1998, 83: 30-33.
11.
Zurück zum Zitat ACR: Breast Imaging Reporting and Data System Atlas (BI-RADS Atlas). Edited by: Reston VA. 2003, American College of Radiology ACR: Breast Imaging Reporting and Data System Atlas (BI-RADS Atlas). Edited by: Reston VA. 2003, American College of Radiology
12.
Zurück zum Zitat Britton PD: Fine needle aspiration or core biopsy. Breast. 1999, 8: 1-4. 10.1016/S0960-9776(99)90329-6.CrossRef Britton PD: Fine needle aspiration or core biopsy. Breast. 1999, 8: 1-4. 10.1016/S0960-9776(99)90329-6.CrossRef
13.
Zurück zum Zitat Britton PD, McCann J: Needle biopsy in the NHS Breast Screening Programme 1996/7: how much and how accurate. Breast. 1999, 8: 5-11. 10.1016/S0960-9776(99)90330-2.CrossRef Britton PD, McCann J: Needle biopsy in the NHS Breast Screening Programme 1996/7: how much and how accurate. Breast. 1999, 8: 5-11. 10.1016/S0960-9776(99)90330-2.CrossRef
14.
Zurück zum Zitat Pisano ED, Fajardo LL, Tsimikas J, Sneige N, Frable WJ, Gatsonis CA, Evans WP, Tocino I, McNeil BJ: Rate of insufficient samples for fine-needle aspiration for non-palpable breast lesions in a multicenter clinical trial: the radiologic diagnostic oncology group 5 study. Cancer. 1999, 82: 678-688. Pisano ED, Fajardo LL, Tsimikas J, Sneige N, Frable WJ, Gatsonis CA, Evans WP, Tocino I, McNeil BJ: Rate of insufficient samples for fine-needle aspiration for non-palpable breast lesions in a multicenter clinical trial: the radiologic diagnostic oncology group 5 study. Cancer. 1999, 82: 678-688.
15.
Zurück zum Zitat Takahashi K, Gomi N, Iwase T, Sakamoto G: The role and efficacy of Mammotome biopsy (vacuum-assisted breast biopsy). Nippon Rinsho. 2006, 64: 469-474. Takahashi K, Gomi N, Iwase T, Sakamoto G: The role and efficacy of Mammotome biopsy (vacuum-assisted breast biopsy). Nippon Rinsho. 2006, 64: 469-474.
16.
Zurück zum Zitat Hoorntje LE, Peeters PH, Mali WP, Borel Rinks IH: Vacuum-assisted breast-biopsy:a critical review. Eur J Cancer. 2003, 39: 1676-1683. 10.1016/S0959-8049(03)00421-0.CrossRefPubMed Hoorntje LE, Peeters PH, Mali WP, Borel Rinks IH: Vacuum-assisted breast-biopsy:a critical review. Eur J Cancer. 2003, 39: 1676-1683. 10.1016/S0959-8049(03)00421-0.CrossRefPubMed
17.
Zurück zum Zitat Mendez A, Cabanillas F, Echenique M, Malekshamran K, Perez I, Ramos E: Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted biopsy (SVABB). Ann Oncol. 2003, 14: 450-454. Mendez A, Cabanillas F, Echenique M, Malekshamran K, Perez I, Ramos E: Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted biopsy (SVABB). Ann Oncol. 2003, 14: 450-454.
18.
Zurück zum Zitat Kettritz U, Morack G, Decker T: Stereotactic vacuum-assisted breast biopsies in 500 women with microcalcifications: radiological and pathological correlations. Eur J Radiol. 2005, 55: 270-276. 10.1016/j.ejrad.2004.10.014.CrossRefPubMed Kettritz U, Morack G, Decker T: Stereotactic vacuum-assisted breast biopsies in 500 women with microcalcifications: radiological and pathological correlations. Eur J Radiol. 2005, 55: 270-276. 10.1016/j.ejrad.2004.10.014.CrossRefPubMed
19.
Zurück zum Zitat Dhillon MS, Bradley SA, England DW: Mammotome biopsy: impact on preoperative diagnosis rate. Clin Radiol. 2006, 61: 469-474. Dhillon MS, Bradley SA, England DW: Mammotome biopsy: impact on preoperative diagnosis rate. Clin Radiol. 2006, 61: 469-474.
20.
Zurück zum Zitat Cox D, Bradley S, England D: The significance of mammotome core biopsy specimens without radiographically identifiable microcalcification and their influence on surgical management- A rertospective review histological correlation. Breast. 2006, 15: 210-218. 10.1016/j.breast.2005.06.001.CrossRefPubMed Cox D, Bradley S, England D: The significance of mammotome core biopsy specimens without radiographically identifiable microcalcification and their influence on surgical management- A rertospective review histological correlation. Breast. 2006, 15: 210-218. 10.1016/j.breast.2005.06.001.CrossRefPubMed
21.
Zurück zum Zitat Cangiarella J, Waisman J, Symmans F, Cohen JM, Wu H, Axelrod D: Mammotome core biopsy for mammary microcalcification. Analysis of 160 biopsies from 142 women with surgical and radiologic follow-up. Cancer. 2001, 91: 173-177. 10.1002/1097-0142(20010101)91:1<173::AID-CNCR22>3.0.CO;2-9.CrossRefPubMed Cangiarella J, Waisman J, Symmans F, Cohen JM, Wu H, Axelrod D: Mammotome core biopsy for mammary microcalcification. Analysis of 160 biopsies from 142 women with surgical and radiologic follow-up. Cancer. 2001, 91: 173-177. 10.1002/1097-0142(20010101)91:1<173::AID-CNCR22>3.0.CO;2-9.CrossRefPubMed
22.
Zurück zum Zitat Diebold T, Jacobi V, Krapfl E, von Minckwitz G, Solbach C, Ballenberger S, Hochmuth K, Balzer JO, Fellbaum M, Kaufmann M, Vogl TJ: [The role of stereotactic 11G vacuum biopsy for clarification of BI-RADS IV findings in mammography]. Rofo. 2003, 175: 489-494.CrossRefPubMed Diebold T, Jacobi V, Krapfl E, von Minckwitz G, Solbach C, Ballenberger S, Hochmuth K, Balzer JO, Fellbaum M, Kaufmann M, Vogl TJ: [The role of stereotactic 11G vacuum biopsy for clarification of BI-RADS IV findings in mammography]. Rofo. 2003, 175: 489-494.CrossRefPubMed
23.
Zurück zum Zitat Yamamoto D, Yamada M, Okugawa H, Tanaka K: Predicting invasion in mammographically detected microcalcifcation: a preliminary report. World J Surg Oncol. 2004, 2: 8-10.1186/1477-7819-2-8.PubMedCentralCrossRefPubMed Yamamoto D, Yamada M, Okugawa H, Tanaka K: Predicting invasion in mammographically detected microcalcifcation: a preliminary report. World J Surg Oncol. 2004, 2: 8-10.1186/1477-7819-2-8.PubMedCentralCrossRefPubMed
24.
Zurück zum Zitat Mori M, Tada K, Ikenaga M, Miyagi Y, Nishimura S, Takahashi K, Makita M, Iwase T, Kasumi F, Koizumi M: Frozen section is superior to imprint cytology for the intra-operative assessment of sentinel lymph node metastasis in Stage I Breast cancer patients. World J Surg Oncol. 2006, 4: 26-10.1186/1477-7819-4-26.PubMedCentralCrossRefPubMed Mori M, Tada K, Ikenaga M, Miyagi Y, Nishimura S, Takahashi K, Makita M, Iwase T, Kasumi F, Koizumi M: Frozen section is superior to imprint cytology for the intra-operative assessment of sentinel lymph node metastasis in Stage I Breast cancer patients. World J Surg Oncol. 2006, 4: 26-10.1186/1477-7819-4-26.PubMedCentralCrossRefPubMed
25.
Zurück zum Zitat Tew K, Irwig L, Matthews A, Crowe P, Macaskill P: Meta-analysis of sentinel node imprint cytology in breast cancer. Br J Surg. 2005, 92: 1068-1080. 10.1002/bjs.5139.CrossRefPubMed Tew K, Irwig L, Matthews A, Crowe P, Macaskill P: Meta-analysis of sentinel node imprint cytology in breast cancer. Br J Surg. 2005, 92: 1068-1080. 10.1002/bjs.5139.CrossRefPubMed
26.
Zurück zum Zitat Jeruss JS, Hunt KK, Xing Y, Krishnamurthy S, Meric-Bernstam F, Cantor SB, Ross MI, Cormier JN: Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective?. Cancer. 2006, 107: 2328-2336. 10.1002/cncr.22275.CrossRefPubMed Jeruss JS, Hunt KK, Xing Y, Krishnamurthy S, Meric-Bernstam F, Cantor SB, Ross MI, Cormier JN: Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective?. Cancer. 2006, 107: 2328-2336. 10.1002/cncr.22275.CrossRefPubMed
27.
Zurück zum Zitat Pugliese MS, Tickman R, Wang NP, Atwood M, Beatty JD: The Utility of Intraoperative Evaluation of Sentinel Lymph Nodes in Breast Cancer. Ann Surg Oncol. 2006, Pugliese MS, Tickman R, Wang NP, Atwood M, Beatty JD: The Utility of Intraoperative Evaluation of Sentinel Lymph Nodes in Breast Cancer. Ann Surg Oncol. 2006,
28.
Zurück zum Zitat Qureshi NA, Beresford A, Sami S, Boparai R, Gosh S, Carmichael AR: Imprint cytology of needle core-biopsy specimens of breast lesions: Is it a useful adjunt to rapid assessment breast clinics?. Breast. 2006, Qureshi NA, Beresford A, Sami S, Boparai R, Gosh S, Carmichael AR: Imprint cytology of needle core-biopsy specimens of breast lesions: Is it a useful adjunt to rapid assessment breast clinics?. Breast. 2006,
29.
Zurück zum Zitat Farshid G, Downey P, Gill PG: Atypical presentations of screen-detected DCIS Implications for pre-operative assessment and surgical intervention. Breast. 2006, Farshid G, Downey P, Gill PG: Atypical presentations of screen-detected DCIS Implications for pre-operative assessment and surgical intervention. Breast. 2006,
30.
Zurück zum Zitat Klevesath MB, Godwin RJ, Bannon R, Munthali L, Coveney E: Touch imprint cytology of core needle biopsy specimens: a useful method for immediate reporting of symptomatic breast lesions. Eur J Surg Oncol. 2005, 31: 490-494. 10.1016/j.ejso.2005.01.004.CrossRefPubMed Klevesath MB, Godwin RJ, Bannon R, Munthali L, Coveney E: Touch imprint cytology of core needle biopsy specimens: a useful method for immediate reporting of symptomatic breast lesions. Eur J Surg Oncol. 2005, 31: 490-494. 10.1016/j.ejso.2005.01.004.CrossRefPubMed
31.
Zurück zum Zitat Carmichael AR, Ninkovic G, Boparai R: The impact of intra-operative specimen radiographs on specimen weights for wide local excision of breast cancer. Breast. 2004, 13: 325-328. 10.1016/j.breast.2004.01.010.CrossRefPubMed Carmichael AR, Ninkovic G, Boparai R: The impact of intra-operative specimen radiographs on specimen weights for wide local excision of breast cancer. Breast. 2004, 13: 325-328. 10.1016/j.breast.2004.01.010.CrossRefPubMed
32.
Zurück zum Zitat Hughson AV, Cooper AV, McArdle CS, Smit DC: Psychosocial morbidity in patients awaiting breast biopsy. J Psychosom Res. 1988, 32: 173-180. 10.1016/0022-3999(88)90052-9.CrossRefPubMed Hughson AV, Cooper AV, McArdle CS, Smit DC: Psychosocial morbidity in patients awaiting breast biopsy. J Psychosom Res. 1988, 32: 173-180. 10.1016/0022-3999(88)90052-9.CrossRefPubMed
33.
Zurück zum Zitat Northouse LL, Jeffs M, Cracchiolo-Caraway A, Lampman L, Dorris G: Emotional distress reported by women and husbands prior to a breast biopsy. Nurs Res. 1995, 44: 196-201. 10.1097/00006199-199507000-00002.CrossRefPubMed Northouse LL, Jeffs M, Cracchiolo-Caraway A, Lampman L, Dorris G: Emotional distress reported by women and husbands prior to a breast biopsy. Nurs Res. 1995, 44: 196-201. 10.1097/00006199-199507000-00002.CrossRefPubMed
34.
Zurück zum Zitat Scott DW: Anxiety, critical thinking and information processing during and after breast biopsy. Nurs Res. 1983, 32: 24-28. 10.1097/00006199-198301000-00006.CrossRefPubMed Scott DW: Anxiety, critical thinking and information processing during and after breast biopsy. Nurs Res. 1983, 32: 24-28. 10.1097/00006199-198301000-00006.CrossRefPubMed
35.
Zurück zum Zitat Goldberg JA, Scott RN, Davidson PM, Murray GD, Stallard S, George WD, Maguire GP: Psychological morbidity in the first year after breast surgery. Eur J Surg Oncol. 1992, 18: 327-331.PubMed Goldberg JA, Scott RN, Davidson PM, Murray GD, Stallard S, George WD, Maguire GP: Psychological morbidity in the first year after breast surgery. Eur J Surg Oncol. 1992, 18: 327-331.PubMed
36.
Zurück zum Zitat Scheier MF, Carver CS: Dispositional optimism and physical well-being: the influence of generalized outcome expectancies on health. J Pers. 1987, 55: 169-210. 10.1111/j.1467-6494.1987.tb00434.x.CrossRefPubMed Scheier MF, Carver CS: Dispositional optimism and physical well-being: the influence of generalized outcome expectancies on health. J Pers. 1987, 55: 169-210. 10.1111/j.1467-6494.1987.tb00434.x.CrossRefPubMed
37.
Zurück zum Zitat Bugbee M, Wellisch D, Arnott I, Maxwell J, Kirsch D, Sayre J, Bassett L: Breast core- needle biopsy: clinical trial of relaxation technique versus medication versus no intervention for anxiety reduction. Radiology. 2005, 234: 73-78. 10.1148/radiol.2341030163.CrossRefPubMed Bugbee M, Wellisch D, Arnott I, Maxwell J, Kirsch D, Sayre J, Bassett L: Breast core- needle biopsy: clinical trial of relaxation technique versus medication versus no intervention for anxiety reduction. Radiology. 2005, 234: 73-78. 10.1148/radiol.2341030163.CrossRefPubMed
Metadaten
Titel
Imprint cytology on microcalcifications excised by Vacuum-Assisted Breast Biopsy: A rapid preliminary diagnosis
verfasst von
Maria Fotou
Vassiliki Oikonomou
Flora Zagouri
Theodoros N Sergentanis
Afroditi Nonni
Pauline Athanassiadou
Theodora Drouveli
Efstratios atsouris
Evagelia Kotzia
George C Zografos
Publikationsdatum
01.12.2007
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2007
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-5-40

Weitere Artikel der Ausgabe 1/2007

World Journal of Surgical Oncology 1/2007 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.